Marketwire -- London, UK, and Cambridge, MA: 28 October 2008: Cancer drug developer Antisoma plc (LSE: ASM; USOTC: ATSMY) today announced that Eric Dodd has been appointed as Chief Financial Officer with effect from November 3rd 2008 and that he will join the Antisoma Board as an Executive Director.
